# Botulinum Toxin Type A (BOTOX®) Treatment of Masseter Muscle Hypertrophy

> **NCT02010775** · PHASE2 · COMPLETED · sponsor: **Allergan** · enrollment: 187 (actual)

## Conditions studied

- Masseter Muscle Hypertrophy

## Interventions

- **BIOLOGICAL:** botulinum toxin Type A
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT02010775
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-20
- **Primary completion:** 2017-03-07
- **Final completion:** 2017-11-29
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2019-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02010775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02010775, "Botulinum Toxin Type A (BOTOX®) Treatment of Masseter Muscle Hypertrophy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02010775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*